Role of omega-3 fatty acids as a treatment for depression in the perinatal period

References

• Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer H. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research 1999; 85: 275–291
   PubMed Web of Science ®Google Scholar
• Simopoulos A P. Evolutionary aspects of diet and essential fatty acids. World Review of Nutrition and Dietetics 2001; 88: 18–27
   PubMedGoogle Scholar
• Hibbeln J R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression. Journal of Affective Disorders 2002; 69: 15–29
   PubMed Web of Science ®Google Scholar
• Meyer B, Mann N, Lewis J, et al. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003; 38: 391–398
   PubMed Web of Science ®Google Scholar
• Keller J R. Omega-3 fatty acids may be effective in the treatment of depression. Topics in Clinical Nutrition 2000; 17: 21–27
   Google Scholar
• Adams P B, Lawson S, Sanigorski A, Sinclair A J. Arachidonic acid to eicopentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31: S157–S161
   PubMed Web of Science ®Google Scholar
• Cross National Collaborative Group. The changing rate of major depression: cross national comparisons. Journal of American Medical Association 1992; 268: 3098–3105
   PubMed Web of Science ®Google Scholar
• Chen C, Wong J, Lee N, Chan-Ho M, Lau J T, Fung M. The Shatin community mental health survey in Hong Kong II. Archives of General Psychiatry 1993; 50: 125–133
   PubMed Web of Science ®Google Scholar
• Varriainen E, Dianjun D, Marks J S. Mortality, cardiovascular risk factors, and diet in China, Finland and the United States. Public Health Report 1991; 106: 41–46
   Google Scholar
• Hirayasu A. An epidemiological and sociopsychiatric study on the mental and neurologic disorders in an isolated island in Otinawa. Psychiatry Neurology Japan 1969; 71: 301–311
   Google Scholar
• Haruki A. A psychiatric epidemiological and sociopsychiatric survey on mental disorders in Tsuma-mura, Okinoshima Island, Shimane prefecture. Psychiatry Neurology Japan 1972; 74: 301–311
   Google Scholar
• Hibbeln J R, Salem N. Dietary polyunsaturated fatty acids and depression. American Journal of Clinical Nutrition 1995; 62: 1–9
   PubMed Web of Science ®Google Scholar
• Hibbeln J R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression. Journal of Affective Disorders 2002; 69: 15–29
   PubMed Web of Science ®Google Scholar
• Tanskanen A, Hibbeln J, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H. Fish consumption, depression and suicidality in a general population. Archives of General Psychiatry 2001; 58: 512–513
   PubMed Web of Science ®Google Scholar
• Hirayama T. Life-style and mortality: a large census-based cohort study in Japan. Karger, BaselSwitzerland 1990
   Google Scholar
• Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Society of Biology Psychiatry 1998; 43: 315–319
   PubMed Web of Science ®Google Scholar
• Al M DM, van Houwelingen A C, Kester A DM, Hasaart T HM, de Jong A EP, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and its relationship with the neonatal essential fatty acid status. British Journal of Nutrition 1994; 74: 55–68
   Google Scholar
• Holman R T, Johnson S B. Deficiency of essential fats and membrane fluidity during pregnancy and lactation. Proceedings of the National Academy of Science of the USA. 1991; 88: 4835–4839
   Google Scholar
• Hornstra G. Essential fatty acids in mothers and their neonates. American Journal of Clinical Nutrition 2000; 71: 1262S–9S
   PubMed Web of Science ®Google Scholar
• Innis S. Perinatal biochemistry and physiology of long chain PUFA. Journal of Pediatrics 2003; 143: S1–S8
   Web of Science ®Google Scholar
• Hibbeln J, Davis J, Heron J, et al. Low dietary omega-3s and increased depression risk in 14,541 pregnancies. Paper presented at American Psychiatric Annual Meeting;, San Francisco, CA, 2003
   Google Scholar
• Makrides M, Crowther C, Gibson R, et al. Low DHA, not iron, status is associated with symptoms of post-partum depression. Paper presented at 8th Annual Congress of Perinatal Society of Australia and New Zealand, SydneyAustralia, 2004
   Google Scholar
• Harris W S, Connor W E, Lindsey S. Will dietary omega-3 fatty acids change the composition of human milk?. American Journal of Clinical Nutrition 1984; 40: 780–785
   PubMed Web of Science ®Google Scholar
• Makrides M, Neumann M A, Gibson R A. Effect of maternal docohexaenoic acid (DHA) supplementation on breast milk composition. European Journal of Clinical Nutrition 1996; 50: 352–357
   PubMed Web of Science ®Google Scholar
• Makrides M, Gibson R A. Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. American Journal of Clinical Nutrition 2000; 71: 307–311
   PubMed Web of Science ®Google Scholar
• Nemets B, Stahl Z, Belmaker R. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. The American Journal of Psychiatry 2002; 159: 447–479
   Google Scholar
• Peet M, Horrobin D. A dose ranging study of the effects of ethyl-eicopentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry 2002; 59: 913–919
   PubMed Web of Science ®Google Scholar
• Su K P, Huang S Y, Chiu C C, Shen W W. Omega-3 fatty acids in major depressive disorder. A preliminary double blind placebo-controlled trial. European Neuropsychopharmacology 2003; 13: 267–271
   PubMed Web of Science ®Google Scholar
• Marangell L B, Martinez J M, Zboyan H A, Kertz B, Kim H F, Puryear L J. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. American Journal of Psychiatry 2003; 160: 996–998
   PubMed Web of Science ®Google Scholar
• Llorente A M, Jensen C L, Voigt R G, et al. Effect of maternal docohexaenoic acid supplementation on postpartum depression and information processing. American Journal of Obstetrics and Gynaecology 2003; 188: 1348–1353
   PubMed Web of Science ®Google Scholar
• Horrobin D F. Essential fatty acids, psychiatric disorders and neuropathies. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine, D F Horrobin. Wiley-Liss, New York 1990; 305–320
   Google Scholar
• Lee C R, Hamm M W. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane. Journal of Nutrition 1989; 119: 539–546
   PubMed Web of Science ®Google Scholar
• Logan A C. Neurobehavioural aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Alternative Medicine Review 2003; 4: 410–424
   Google Scholar
• Maes M. Fatty acids, cytokines, major depression. Society of Biology Psychiatry 1998; 43: 313–314
   PubMed Web of Science ®Google Scholar
• Lieb J. Lithium and antidepressants: inhibiting eicosanoids, stimulating immunity, and defeating microorganisms. Medical Hypotheses 2002; 59: 429–432
   Google Scholar
• Sapolsky R M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biology Psychiatry 2000; 48: 755–765
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biology Psychiatry 2003; 54: 70–75
   PubMed Web of Science ®Google Scholar
• Ikemoto A, Nitta A, Furukawa S, et al. Dietary omega-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neuroscience Letters 2000; 285: 99–102
   PubMed Web of Science ®Google Scholar
• Kitajka K, Sinclair A J, Weisinger R S, et al. Effects of omega-3 polyunsaturated fatty acids on brain expression. Proceeding of the National Academy of Sciences of the USA. 2004; 101: 10931–10936
   Google Scholar
• Willatts P, Forsyth J S, DiModugno M K, Varma S, Colvin M. Effect of long chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998; 352: 688–691
   PubMed Web of Science ®Google Scholar
• Lucas A, Morley R, Cole T J, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992; 339: 261–264
   PubMed Web of Science ®Google Scholar
• Lanting C I, Fidler V, Huisman M, Touwen B CL, Boersma E R. Neurological differences between 9 year old children fed breast-milk or formula-milk as babies. Lancet 1994; 344: 1319–1322
   PubMed Web of Science ®Google Scholar
• Horwood L J, Ferguson D M. Breastfeeding and later cognitive and academic outcomes. Pediatrics 1998; 101: e9
   PubMedGoogle Scholar
• Daniels J L, Longnecker M P, Rowland A S, Golding J, the ALSPAC Study Team. Epidemiology 2004; 15: 394–402
   PubMed Web of Science ®Google Scholar
• Gibson R A, Chen W, Makrides M. Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: functional and clinical outcomes. Lipids 2001; 36: 873–883
   PubMed Web of Science ®Google Scholar
• Arterburn L M, Boswell K D, Koskelo E, Kassner S L, Kelly C, Kyle D J. A combined subchronic toxicity and neurotoxicity study of a single-cell source of docsahexaenoic acid triglyceride (DHASCO oil). Food and Toxicology 2000; 38: 35–49
   PubMed Web of Science ®Google Scholar
• Burns R A, Wibert G J, Diersen-Schade D A, Kelly C M. Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-month rat oral safety study with an in utero phase. Food and Toxicology 1999; 37: 23–26
   PubMed Web of Science ®Google Scholar
• Olsen S F, Secher N J, Tabor A, Weber T, Walker J J, Gluud C. Randomized clinical trials of fish oil supplementation in high risk pregnancies. British Journal of Obstetrics and Gynaecology 2000; 107: 382–395
   Google Scholar
• Onwude J L, Lilford R J, Hjartardattir H, Staines A, Tuffnell D. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. British Journal of Obstetrics and Gynaecology 1995; 102: 95–100
   PubMedGoogle Scholar
• Austin M-P. Antenatal psychosocial screening, assessment and prevention for ‘perinatal’ distress, depression & anxiety: where to from here?. Archives of Women's Mental Health 2004; 7: 1–6
   PubMedGoogle Scholar
• Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study (ALSPAC) of depressed mood during pregnancy and after childbirth. British Medical Journal 2001; 323: 257–260
   PubMed Web of Science ®Google Scholar
• Kumar R, Robson K. A prospective study of emotional disorders in child bearing women. British Journal of Psychiatry 1984; 144: 35–47
   PubMed Web of Science ®Google Scholar
• NICHD Early Child Care Research Network. Chronicity of maternal depressive symptoms, maternal sensitivity, and child functioning at 36 months. Developmental Psychology 1999; 5: 1297–1310
   Google Scholar
• Murray L, Cooper P. Postpartum depression and child development. Psychological Medicine 1997; 27: 253–260
   PubMed Web of Science ®Google Scholar
• Hammen C, Brennan P. Severity, chronicity and timing of maternal depression and risk for adolescent offspring diagnoses in a community sample. Archives of General Psychiatry 2003; 60: 253–258
   PubMed Web of Science ®Google Scholar
• Williams H, Carmichael A. Depression in mothers and behavioural problems with their preschool children. Journal of Paediatric Child Health 1991; 27: 76–82
   PubMed Web of Science ®Google Scholar
• Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive behavioural counselling in the treatment of postnatal depression. British Medical Journal 1997; 314: 932–936
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clinical Pharmacology and Therapeutics 2003; 73: 330–337
   PubMed Web of Science ®Google Scholar
• Austin M-P, Mitchell P. The use of psychotropic medications in pregnant women. Medical Journal of Australia 1998; 169: 428–431
   Google Scholar
• Hendrick V, Stowe Z N, Altshuler L, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medication. American Journal of Psychiatry 2003; 160: 993–996
   PubMed Web of Science ®Google Scholar
• Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Archives of General Psychiatry 2003; 60: 720–726
   PubMed Web of Science ®Google Scholar
• Costei A, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Archives of Pediatrics and Adolescent Medicine 2002; 156: 1129–1132
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart D E. Neurodevelopment of children exposed in utero to antidepressant drugs. New England Journal of Medicine 1997; 320: 19–23
   Google Scholar
• Austin M-P, Mitchell P. The use of psychotropic medications in breast-feeding women: acute and prophylactic treatment. Australian and New Zealand Journal of Psychiatry 1998; 32: 778–784
   PubMed Web of Science ®Google Scholar